-
The Maryland Maternal Health Act of 2024 seeks to accomplish four goals. It is among hundreds of pieces of legislation awaiting the governor’s review and signature.
-
The next step is for the board to conduct cost reviews of the drugs.
-
The suit claims the companies conspired to increase the cost of insulin.
-
Despite ample time, DDA is still failing to ensure services are being provided.
-
The attack is impacting medication distribution worldwide.
-
Maryland scientists help expand use of drug that could revolutionize life for food allergy sufferersThe drug helps dampen effects of severe allergic reactions.
-
The law would protect workers from out-of-state legal challenges.
-
If passed, pharmacists could administer vaccines to children as young as 5.
-
A new bill would allow the board to review drugs for the whole state.
-
The bills are aimed at nurses and EMTs.